期刊文献+

食源性晚期糖基化终末产物与非酒精性脂肪肝关系的研究进展 被引量:1

Research Progress in Relationship between Dietary Advanced Glycation End Products and Nonalcoholic Fatty Liver Disease
下载PDF
导出
摘要 非酒精性脂肪肝(NAFLD)是一组获得性的代谢应激相关性肝病,而晚期糖基化终末产物(AGEs)在NAFLD发病中起着重要的作用。食源性AGEs是人体内AGEs的主要贡献者,食源性AGEs可通过非受体结合的方式、受体结合的方式、影响肠道菌群发挥作用等多种机制促进NAFLD的发生与发展。AGEs特异性受体(RAGE)及RAGE下游信号通路的阻断、基因的敲除或食源性AGEs摄入限制等方法可能成为治疗此类肝病的有效手段,还需更大样本量的临床研究探求食源性AGEs影响NAFLD的确切机制。 Objective Nonalcoholic fatty liver disease(NAFLD) represents a spectrum of acquired metabolic stress-related liver diseases.The advanced glycation end products(AGEs) play an important role in the pathogenesis of NAFLD.As the main contributors to AGEs in the human body,dietary AGEs can promote the occurrence and development of NAFLD through a variety of mechanisms,including non-receptor binding,receptor binding and affecting intestinal flora.The blocking of AGE-specific cellular receptor(RAGE) and its downstream signaling pathway,gene knockout or restriction of dietary AGEs may be effective methods for the treatment of NAFLD.However,more clinical studies are needed to determine the exact mechanisms of the effect of dietary advanced glycation products on NAFLD.
作者 蔡魏 徐积兄 邱剑 CAI wei;XU Ji-xiong;QIU Jian(Medical Department of Graduate School,the First Affiliated Hospital,Nanchang University,Nanchang 330006,China;Department of Endocrinology,the First Affiliated Hospital,Nanchang University,Nanchang 330006,China;Department of Endocrinology,the Third People’s Hospital of Jiujiang,Jiujiang 332000,China;Department of General Surgery,the Third People’s Hospital of Jiujiang,Jiujiang 332000,China)
出处 《南昌大学学报(医学版)》 CAS 2020年第2期95-98,104,共5页 Journal of Nanchang University:Medical Sciences
基金 国家自然科学基金(81760618)。
关键词 非酒精性脂肪肝 食源性晚期糖基化终末产物 晚期糖基化终末产物特异性受体 机制 nonalcoholic fatty liver disease dietary advanced glycation end products AGE-specific cellular receptor mechanism
  • 相关文献

参考文献3

二级参考文献22

  • 1Ferlay Jacques,Shin Hai-Rim,Bray Freddie,Forman David,Mathers Colin,Parkin Donald Maxwell.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. Journal international du cancer . 2011
  • 2Katsutoshi Tokushige,Etsuko Hashimoto,Kazuhiko Kodama.Hepatocarcinogenesis in non‐alcoholic fatty liver disease in J apan[J].J Gastroenterol Hepatol.2013
  • 3DM Parkin,F Bray,J Ferlay,P Pisani.Global cancer statistics, 2002. CA: a cancer journal for clinicians . 2005
  • 4Cristina Bosetti,Federica Turati,Carlo La Vecchia.Hepatocellular carcinoma epidemiology[J]. Best Practice & Research Clinical Gastroenterology . 2014 (5)
  • 5Vinicio Carloni,Tu Vinh Luong,Krista Rombouts.Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever[J]. Liver Int . 2014 (6)
  • 6Ryusuke Ito,Yuji Ishii,Shigeki Wakiyama,Hiroaki Shiba,Shuichi Fujioka,Takeyuki Misawa,Yuichi Ishida,Hiroshi Hano,Katsuhiko Yanaga.Prognostic significance of receptor for advanced glycation end products expression in hepatocellular carcinoma after hepatectomy[J]. Journal of Surgical Research . 2014
  • 7Ruo-Chan Chen,Pan-Pan Yi,Rong-Rong Zhou,Mei-Fang Xiao,Ze-Bing Huang,Dao-Lin Tang,Yan Huang,Xue-Gong Fan.The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines[J]. Molecular and Cellular Biochemistry . 2014 (1-2)
  • 8Cédric Coulouarn,Bruno Clément.Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma[J]. Journal of Hepatology . 2014
  • 9A. Kuhla,J. Norden,K. Abshagen,M. D. Menger,B. Vollmar.RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure[J]. Br J Surg . 2013 (9)
  • 10Eun‐Ji Koh,Seong‐Jin Yoon,Sun‐Mee Lee.Losartan protects liver against ischaemia/reperfusion injury through PPAR ‐ γ activation and receptor for advanced glycation end‐products down‐regulation[J]. Br J Pharmacol . 2013 (6)

共引文献128

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部